Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epipharyngeal Abrasion Therapy with Zinc Chloride for Glomerulopathy
jRCTs041190011Suspended
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Zinc chloride in Glomerulonephritis (GN) and glomerulopathy. Primary endpoint: Remission of proteinuria or hematuria. Started Aug 2012; status: suspended.
02
Drugs
Zinc chloride
03
Conditions
Glomerulonephritis (GN)glomerulopathy
Beyond the preview
Go deeper on jRCTs041190011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190011.